CVS vs BMY
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 14, 2026
CVS
65.0
AI Score
VS
CVS Wins
BMY
62.4
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CVS | BMY | Winner |
|---|---|---|---|
| Revenue | 189.89B | 11.49B | CVS |
| Net Income | 4.89B | 2.68B | CVS |
| Net Margin | 2.6% | 23.3% | BMY |
| ROE | 7.8% | 13.3% | BMY |
| ROA | 2.2% | 3.1% | BMY |
| Total Assets | 220.11B | 86.48B | CVS |
| Cash | 5.19B | 9.57B | BMY |
| Debt/Equity | 1.10 | 2.20 | CVS |
| Current Ratio | 0.92 | 1.42 | BMY |
| Free Cash Flow | 8.32B | 757.00M | CVS |
Frequently Asked Questions
Based on our detailed analysis, CVS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.